請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/79032
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 顏毅廣(Yi-Kuang Yen) | |
dc.contributor.author | Chao-Yuan Chiu | en |
dc.contributor.author | 丘朝元 | zh_TW |
dc.date.accessioned | 2021-07-11T15:38:13Z | - |
dc.date.available | 2023-08-21 | |
dc.date.copyright | 2018-08-21 | |
dc.date.issued | 2018 | |
dc.date.submitted | 2018-08-14 | |
dc.identifier.citation | [1] R. S. Fisher et al., 'Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology,' Epilepsia, vol. 58, no. 4, pp. 522-530, 2017.
[2] W. W. Lytton, 'Computers, causality and cure in epilepsy,' Brain, vol. 140, no. 3, pp. 516-526, 2017. [3] 张玉凤, 张利华, 李亚军, and 张蓓, '精准医学在癫痫中的应用,' 脑与神经疾病杂志, vol. 1, p. 017, 2018. [4] 谭启富, '有关癫痫的手术治疗问题,' 中国医刊, vol. 40, no. 5, pp. 5-7, 2005. [5] N. K. Schiltz and G. F.-B. Vaca, 'Epidemiologist’s view: Addressing the epilepsy surgery treatment gap with minimally-invasive techniques,' Epilepsy research, 2018. [6] P. Striano, S. Striano, C. Minetti, and F. Zara, 'Refractory, life-threatening status epilepticus in a 3-year-old girl,' The Lancet Neurology, vol. 7, no. 3, pp. 278-284, 2008. [7] E. Perucca, L. Gram, G. Avanzini, and O. Dulac, 'Antiepileptic drugs as a cause of worsening seizures,' Epilepsia, vol. 39, no. 1, pp. 5-17, 1998. [8] I. Kacirova and M. Grundmann, 'Importance of TDM During Pregnancy and Breastfeeding,' Clinical Therapeutics, vol. 39, no. 8, pp. e92-e93, 2017. [9] Z. Chen, M. J. Brodie, D. Liew, and P. Kwan, 'Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic drugs: a 30-year longitudinal cohort study,' JAMA neurology, 2017. [10] A. Groth, T. Wilke, S. Borghs, P. Gille, and L. Joeres, 'Real life pharmaceutical treatment patterns for adult patients with focal epilepsy in Germany: a longitudinal and cross-sectional analysis of recently approved anti-epileptic drugs,' GMS German Medical Science, vol. 15, 2017. [11] 陳獻宗, 現代神經學. 2003. [12] N. Scheinfeld, 'Phenytoin in cutaneous medicine: Its uses and side effects,' Dermatology online journal, vol. 9, no. 3, 2003. [13] S. Sen et al., 'Treatment of phenytoin toxicity by the molecular adsorbents recirculating system (MARS),' Epilepsia, vol. 44, no. 2, pp. 265-267, 2003. [14] AboutKidsHealth-苯妥英. Available: https://www.aboutkidshealth.ca [15] A+醫學百科-苯妥英鈉. Available: http://cht.a-hospital.com/w/%E5%8C%BB%E9%99%A2%E8%8D%AF%E5%AD%A6/%E8%8B%AF%E5%A6%A5%E8%8B%B1%E9%92%A0 [16] DREYFUS HEALTH FOUNDATION. Available: https://www.dhfglobal.org/ [17] J. Fritz et al., 'Translating biomolecular recognition into nanomechanics,' Science, vol. 288, no. 5464, pp. 316-318, 2000. [18] G. Wu, R. H. Datar, K. M. Hansen, T. Thundat, R. J. Cote, and A. Majumdar, 'Bioassay of prostate-specific antigen (PSA) using microcantilevers,' Nature biotechnology, vol. 19, no. 9, p. 856, 2001. [19] J. W. Ndieyira et al., 'Nanomechanical detection of antibiotic–mucopeptide binding in a model for superbug drug resistance,' Nature nanotechnology, vol. 3, no. 11, p. 691, 2008. [20] Z. Zhang, Y. Murakami, T. Taniguchi, M. Sohgawa, K. Yamashita, and M. Noda, 'A Cantilever‐based Biosensor for Real‐time Monitoring of Interactions between Amyloid‐β (1–40) and Membranes Comprised of Phosphatidylcholine Lipids with Different Hydrophobic Acyl Chains,' Electroanalysis, vol. 29, no. 3, pp. 722-729, 2017. [21] C.-W. Huang et al., 'A fully integrated wireless CMOS microcantilever lab chip for detection of DNA from Hepatitis B virus (HBV),' Sensors and Actuators B: Chemical, vol. 181, pp. 867-873, 2013. [22] A. Dehe, K. Fricke, K. Mutamba, and H. Hartnagel, 'A piezoresistive GaAs pressure sensor with GaAs/AlGaAs membrane technology,' Journal of Micromechanics and Microengineering, vol. 5, no. 2, p. 139, 1995. [23] F. Loizeau et al., 'Piezoresistive membrane-type surface stress sensor arranged in arrays for cancer diagnosis through breath analysis,' in Micro Electro Mechanical Systems (MEMS), 2013 IEEE 26th International Conference on, 2013, pp. 621-624: IEEE. [24] C. Pramanik, H. Saha, and U. Gangopadhyay, 'Design optimization of a high performance silicon MEMS piezoresistive pressure sensor for biomedical applications,' Journal of Micromechanics and Microengineering, vol. 16, no. 10, p. 2060, 2006. [25] G. Yoshikawa et al., 'Two dimensional array of piezoresistive nanomechanical membrane-type surface stress sensor (MSS) with improved sensitivity,' Sensors, vol. 12, no. 11, pp. 15873-15887, 2012. [26] E. Market and F. N. Papavasiliou, 'V (D) J recombination and the evolution of the adaptive immune system,' PLoS biology, vol. 1, no. 1, p. e16, 2003. [27] B. J. Underdown and J. M. Schiff, 'Immunoglobulin A: strategic defense initiative at the mucosal surface,' Annual review of immunology, vol. 4, no. 1, pp. 389-417, 1986. [28] R. Geisberger, M. Lamers, and G. Achatz, 'The riddle of the dual expression of IgM and IgD,' Immunology, vol. 118, no. 4, pp. 429-437, 2006. [29] K. Chen et al., 'Immunoglobulin D enhances immune surveillance by activating antimicrobial, proinflammatory and B cell–stimulating programs in basophils,' Nature immunology, vol. 10, no. 8, p. 889, 2009. [30] C. Janeway, Immunobiology: The Immune System in Health and Disease. 2001. [31] C. L. Stanfield, Human Physiology: An Integrated Approach [32] E. Maverakis et al., 'Glycans in the immune system and The Altered Glycan Theory of Autoimmunity: a critical review,' Journal of autoimmunity, vol. 57, pp. 1-13, 2015. [33] 洪維廷, '應用壓阻式微懸臂梁生物感測器偵測巴斯德桿菌之研究,' 臺灣大學應用力學研究所學位論文, pp. 1-103, 2009. [34] K. Matsudaira, T.-V. Nguyen, K. H. Shoji, T. Tsukagoshi, T. Takahata, and I. Shimoyama, 'MEMS piezoresistive cantilever for the direct measurement of cardiomyocyte contractile force,' Journal of Micromechanics and Microengineering, vol. 27, no. 10, p. 105005, 2017. [35] Y. Zhang, M. A. Arugula, M. Wales, J. Wild, and A. L. Simonian, 'A novel layer-by-layer assembled multi-enzyme/CNT biosensor for discriminative detection between organophosphorus and non-organophosphrus pesticides,' Biosensors and Bioelectronics, vol. 67, pp. 287-295, 2015. [36] C. Fung, J. Lloyd, S. Samavat, D. Deganello, and K. Teng, 'Facile fabrication of electrochemical ZnO nanowire glucose biosensor using roll to roll printing technique,' Sensors and Actuators B: Chemical, vol. 247, pp. 807-813, 2017. [37] C. Ziegler and W. Göpel, 'Biosensor development,' Current opinion in chemical biology, vol. 2, no. 5, pp. 585-591, 1998. [38] L. D. Mello and L. T. Kubota, 'Review of the use of biosensors as analytical tools in the food and drink industries,' Food chemistry, vol. 77, no. 2, pp. 237-256, 2002. [39] F. S. Diba, S. Kim, and H. J. Lee, 'Amperometric bioaffinity sensing platform for avian influenza virus proteins with aptamer modified gold nanoparticles on carbon chips,' Biosensors and Bioelectronics, vol. 72, pp. 355-361, 2015. [40] I. Will, A. Ding, and Y. Xu, 'Shape and Proximity Effect of Magnetic Nanoelements Used as Biomolecular Labels for Magnetic Notched Nanowire Biosensors,' IEEE Transactions on Magnetics, vol. 50, no. 3, pp. 49-53, 2014. [41] V. L. Kopparthy, S. M. Tangutooru, and E. J. Guilbeau, 'Label free detection of L-glutamate using microfluidic based thermal biosensor,' Bioengineering, vol. 2, no. 1, pp. 2-14, 2015. [42] 李建武, 生物化學實驗原理和方法. 1997. [43] G. F. Bickerstaff, 'Immobilization of enzymes and cells,' in Immobilization of enzymes and cells: Springer, 1997, pp. 1-11. [44] P. Gonzalez, M. Rakowski, D. San Segundo, S. Severi, K. De Meyer, and A. Witvrouw, 'CMOS-integrated poly-SiGe piezoresistive pressure sensor,' IEEE Electron Device Letters, vol. 33, no. 8, pp. 1204-1206, 2012. [45] 張凱峯, '利用電場操控蛋白質佈植於壓阻式生物感測器之藥物治療監測應用,' 臺灣大學應用力學研究所學位論文, pp. 1-112, 2012. [46] A. Moulin, S. O'shea, R. Badley, P. Doyle, and M. Welland, 'Measuring surface-induced conformational changes in proteins,' Langmuir, vol. 15, no. 26, pp. 8776-8779, 1999. [47] H.-F. Ji, E. Finot, R. Dabestani, T. Thundat, G. M. Brown, and P. F. Britt, 'A novel self-assembled monolayer (SAM) coated microcantilever for low level caesium detection,' Chemical Communications, no. 6, pp. 457-458, 2000. [48] 辜煜夫, '壓阻式微懸臂梁生化感測系統溫度效應之量測, 消除與應用,' 臺灣大學應用力學研究所學位論文, pp. 1-190, 2009. [49] J. Thaysen, Cantilever for bio-chemical sensing integrated in a microliquid handling system. Technical University of Denmark, 2001. [50] F. T. Goericke and W. P. King, 'Modeling piezoresistive microcantilever sensor response to surface stress for biochemical sensors,' IEEE Sensors Journal, vol. 8, no. 8, pp. 1404-1410, 2008. [51] F. T. Goericke, 'Simulation, fabrication and characterization of piezoresistive bio-/chemical sensing microcantilevers,' Georgia Institute of Technology, 2007. [52] A. Choudhury, P. J. Hesketh, T. Thundat, and Z. Hu, 'A piezoresistive microcantilever array for surface stress measurement: curvature model and fabrication,' Journal of Micromechanics and Microengineering, vol. 17, no. 10, p. 2065, 2007. [53] J. Thaysen, R. Marie, and A. Boisen, 'Cantilever-based bio-chemical sensor integrated in a microliquid handling system,' in Micro Electro Mechanical Systems, 2001. MEMS 2001. The 14th IEEE International Conference on, 2001, pp. 401-404: IEEE. [54] R. Treml et al., 'High resolution determination of local residual stress gradients in single-and multilayer thin film systems,' Acta Materialia, vol. 103, pp. 616-623, 2016. [55] 李冠緯, 'CMOS-BioMEMS 壓阻式微懸臂樑生物感測器於 腹膜炎治療藥物慶大黴素檢測之研究,' 臺灣大學應用力學研究所學位論文, pp. 1-103, 2017. [56] G. Yoshikawa, T. Akiyama, S. Gautsch, P. Vettiger, and H. Rohrer, 'Nanomechanical membrane-type surface stress sensor,' Nano letters, vol. 11, no. 3, pp. 1044-1048, 2011. [57] J. Harkey and T. W. Kenny, '1/f noise considerations for the design and process optimization of piezoresistive cantilevers,' Journal of microelectromechanical systems, vol. 9, no. 2, pp. 226-235, 2000. [58] Y.-F. Ku, L.-S. Huang, and Y.-K. Yen, 'A Real-Time Thermal Self-Elimination Method for Static Mode Operated Freestanding Piezoresistive Microcantilever-Based Biosensors,' Biosensors, vol. 8, no. 1, p. 18, 2018. [59] 林隆翊, '壓阻式微懸臂樑生物感測元件於抗癲癇藥物之研究,' 臺灣大學應用力學研究所學位論文, pp. 1-87, 2012. [60] 'Preparing Self-Assembled Monolayers (SAMs), A Step-by-Step Guide for Solution-Based Self-Assembly ', ed: SIGMA-ALDRICH. [61] Material Matters, Molecular Self-Assembly vol.1. SIGMA-ALDRICH, 2006. [62] T. Scientific, 'Crosslinking technical handbook,' Thermo Fisher Scientific Inc., Waltham, 2012. [63] Thermo Scientific™ Avantage™ Data System for XPS Available: https://xpssimplified.com/periodictable.php [64] M. Wirde, U. Gelius, and L. Nyholm, 'Self-assembled monolayers of cystamine and cysteamine on gold studied by XPS and voltammetry,' Langmuir, vol. 15, no. 19, pp. 6370-6378, 1999. [65] B. Ilic, D. Czaplewski, H. G. Craighead, P. Neuzil, C. Campagnolo, and C. Batt, 'Mechanical resonant immunospecific biological detector,' Applied physics letters, vol. 77, no. 3, pp. 450-452, 2000. [66] A. Brecht, J. Ingenhoff, and G. Gauglitz, 'Direct monitoring of antigen-antibody interactions by spectral interferometry,' Sensors and Actuators B: Chemical, vol. 6, no. 1-3, pp. 96-100, 1992. [67] Q. Lin, X. Ding, F. Qiu, X. Song, G. Fu, and J. Ji, 'In situ endothelialization of intravascular stents coated with an anti-CD34 antibody functionalized heparin–collagen multilayer,' Biomaterials, vol. 31, no. 14, pp. 4017-4025, 2010. [68] A. D. McNaught and A. D. McNaught, Compendium of chemical terminology. Blackwell Science Oxford, 1997. [69] J. Pierson-Perry et al., 'EP17-A2 Evaluation of Detection Capability for Clinical Laboratory Measurement Procedures,' Approved Guideline, Clinical and Laboratory Standards Institute, vol. 950, 2012. [70] D. A. Armbruster and T. Pry, 'Limit of blank, limit of detection and limit of quantitation,' The Clinical Biochemist Reviews, vol. 29, no. Suppl 1, p. S49, 2008. [71] G. L. Long and J. D. Winefordner, 'Limit of detection. A closer look at the IUPAC definition,' Analytical Chemistry, vol. 55, no. 7, pp. 712A-724A, 1983. [72] T. A. Little, 'Method validation essentials, limit of blank, limit of detection, and limit of quantitation,' ed: ADVANSTAR COMMUNICATIONS INC 131 W 1ST STREET, DULUTH, MN 55802 USA, 2015. [73] A. Shrivastava and V. B. Gupta, 'Methods for the determination of limit of detection and limit of quantitation of the analytical methods,' Chronicles of young scientists, vol. 2, no. 1, p. 21, 2011. [74] J. Mocak, A. Bond, S. Mitchell, and G. Scollary, 'A statistical overview of standard (IUPAC and ACS) and new procedures for determining the limits of detection and quantification: application to voltammetric and stripping techniques (technical report),' Pure and Applied Chemistry, vol. 69, no. 2, pp. 297-328, 1997. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/79032 | - |
dc.description.abstract | 本研究主要針對治療癲癇症之藥物苯妥英(Phenytoin)血液中藥物濃度監測開發即時偵測微型生物晶片。苯妥英在血液中之有效治療濃度區間非常狹窄,且治療劑量與中毒劑量非常接近,因此,需要一個微型感測器密集的監測血液中的藥物濃度。根據全國藥物不良反應通報中心統計,苯妥英藥物不良通報數名列前十,是藥物治療監測(TDM)的重要監測藥物之一。
現行檢測小分子藥物之檢驗儀器體積龐大、費用昂貴,檢驗流程繁瑣無法即時檢測,容易錯估病人的病情或造成藥物副作用的產生,且隨健康意識的抬頭,針對微型化之即時感測器的需求也日益提升,而壓阻式力學感測器具有即時量測小分子藥物之潛力,於是本研究開發以力學基礎量測的生物感測晶片,以壓阻式微懸臂樑感測器為基礎,改良設計一個橋狀薄膜結構,增強結構上的穩定而不失去訊號靈敏度,利用 CIC下線方式製作標準 CMOS 製程壓阻式橋狀薄膜感測晶片,此外,為求此生物感測器可落實便利性,以低成本的方式進行密閉式封裝,提供感測器一個固定的量測環境,製作一個低成本、微型化、高靈敏度、可定量檢測、使用微量檢體且可即時監測之小分子藥物生物感測器。 本研究利用抗體與抗原間的專一性鍵結固定待測藥物苯妥英於橋狀薄膜表面,鍵結時產生的分子構型變化使橋狀薄膜產生應力應變,透過壓阻材料來產生電訊號的改變,因此不受限於小分子藥物的質量限制。由實驗結果得知橋狀薄膜感測器較微懸臂樑感測器提升了約8倍的訊號改變量,且成功對濃度為5 ug/mL、10 ug/mL、35 ug/mL、50 ug/mL、100 ug/mL的本妥英藥物進行定量量測,得到藥物濃度對電阻變化量之線性曲線。本研究壓阻式橋狀薄膜生物感測器之可量測最小濃度(LOD)為5.69 μg/mL,可定量最小濃度(LOQ)為27.35 μg/mL,可量測濃度區間為5.69 μg/mL ~100 μg/mL,苯妥英有效濃度範圍均落在量測濃度區間內,證實本研究之壓阻式橋狀薄膜生物感測器在量測小分子藥物上具有一定的潛力且擁有定量分析之能力。 | zh_TW |
dc.description.abstract | This study focused on the development of pizoresistive membrane-bridge to monitor the concentration of Phenytoin in blood. Phenytoin is a widely used drug for the treatment of epilepsy. The effective therapeutic concentration range of phenytoin in the blood is very narrow, and the therapeutic dose is very close to the toxic dose. Therefore, a micro-sensor is needed to monitor the concentration of the drug in the blood intensively. According to the National Adverse Drug Reactions (ADRs) Reporting System, the number of phenytoin adverse drug notifications ranked in the top ten.It’s one of the important drugs for drug treatment monitoring (TDM).
The current testing instruments for detecting small molecule drugs are bulky and expensive. The inspection process is complicated and undetected immediately. It is easy to misdiagnose the patient's condition or cause side effects of the drug. With the rise of health awareness, the demand for miniaturized sensor is increasing, and the piezoresistive mechanical sensor has the potential to measure small molecule drugs in real time. Therefore, this study develops a biosensor on mechanical basis measurement. Based on a piezoresistive microcantilever sensor, an improved membrane-bridge structure is designed to enhance structural stability without losing signal sensitivity. The Piezoresistive membrane-bridge made by TSMC CMOS MEMS 0.35 standard process, and a low cost, hermetic package that provides a stable measurement environment for the sensor. The Piezoresistive membrane-bridge is a small molecule drag biosensor with low cost, miniaturization, high sensitivity, quantitative detection and small amount of sample for real time monitoring. By comparing the experimental result, the membrane-bridge sensor has about 8 times more signal than the Microcantilever sensor. The membrane-bridge biosensor successfully measured the different concentration of Phenytoin which contain 5 ug/mL、10 ug/mL、35 ug/mL、50 ug/mL、100 ug/mL . A linear curve of drug concentration versus resistance change is obtained. The effective therapeutic concentration range of phenytoin was within the measurement concentration range, which confirmed that the piezoresistive membrane-bridge biosensor of this study has certain potential in measuring small molecule drugs and has the ability of quantitative analysis. | en |
dc.description.provenance | Made available in DSpace on 2021-07-11T15:38:13Z (GMT). No. of bitstreams: 1 ntu-107-R05543012-1.pdf: 5893017 bytes, checksum: c1416a086817b5594a140885eb01c6eb (MD5) Previous issue date: 2018 | en |
dc.description.tableofcontents | 致謝 i
中文摘要 ii ABSTRACT iii 圖目錄 vii 表目錄 x 第一章 緒論 1 1-1. 前言 1 1-2. 研究動機與目的 1 1-3. 文獻回顧 3 1-4. 論文大綱 10 第二章 生物感測器之原理與介紹 12 2-1. 生物的免疫反應 12 2-2. 生物感測器基本原理 16 2-3. 表面分子辨識層技術 17 第三章 CMOS-MEMS壓阻式橋狀薄膜之理論與設計 19 3-1. 壓阻式微感測器應力機制與分析 19 3-2. 壓阻材料尺寸設計 25 3-3. 橋狀薄膜理論 28 3-4. 雜訊分析 30 3-5. CMOS MEMS壓阻式橋狀薄膜製程與功能設計 32 第四章 CMOS MEMS壓阻式橋狀薄膜晶片製作與量測 35 4-1. 壓阻式橋狀薄膜晶片製作 35 4-2. 生物感測器設計與製作 36 4-3. 壓阻式橋狀薄膜機電特性 40 4-4. 熱效應自補償系統 43 4-5. 藥物量測實驗架構與方法 45 第五章 實驗結果與討論 50 5-1. 表面分子辨識層之化學鍵結分析 50 5-2. 橋狀薄膜晶片及微懸臂樑晶片量測結果與比較 53 5-3. 不同濃度苯妥英(Phenytoin)之量測與比較 54 5-4. 壓阻式橋狀薄膜量測結果分析 56 第六章 結論與未來展望 63 6-1. 結論 63 6-2. 未來與展望 65 第七章 ACKNOWLEDGEMENT 66 第八章 參考文獻 67 | |
dc.language.iso | zh-TW | |
dc.title | CMOS-BioMEMS壓阻式橋狀薄膜生物感測器於
癲癇小分子藥物苯妥英偵測之研究 | zh_TW |
dc.title | A Study of CMOS-BioMEMS Based Membrane-Bridge Sensor on the Detection of Phenytoin | en |
dc.type | Thesis | |
dc.date.schoolyear | 106-2 | |
dc.description.degree | 碩士 | |
dc.contributor.coadvisor | 張培仁(Pei-Zen Chang) | |
dc.contributor.oralexamcommittee | 盧彥文(Yen-Wen Lu),陳建甫(Chien-Fu Chen) | |
dc.subject.keyword | 橋狀薄膜,小分子量測,苯妥英,藥物治療監測,專一性鍵結, | zh_TW |
dc.subject.keyword | Membrane-bridge,Small molecular measurement,Phenytoin,TDM, | en |
dc.relation.page | 71 | |
dc.identifier.doi | 10.6342/NTU201801372 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2018-08-14 | |
dc.contributor.author-college | 工學院 | zh_TW |
dc.contributor.author-dept | 應用力學研究所 | zh_TW |
dc.date.embargo-lift | 2023-08-21 | - |
顯示於系所單位: | 應用力學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-107-R05543012-1.pdf 目前未授權公開取用 | 5.75 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。